Loading menu…

Retrospective Study Evaluating the Management of Psychotic Disorders at Behavioral Medicine Dept a SQUH

§ Sultan Qaboos University

Send Message

To: Author

Retrospective Study Evaluating the Management of Psychotic Disorders at Behavioral Medicine Dept a SQUH

Article Fingerprint

ReserarchID

IFS81

Retrospective Study Evaluating the Management of Psychotic Disorders at Behavioral Medicine Dept a SQUH Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Reading Preferences
Font Size
Line Spacing
Background
This converted HTML version may contain rendering inconsistencies. Please refer to the PDF for the authoritative version, or click here to provide feedback.

Abstract

Introduction-Hundreds of millions of people worldwide are affected by mental, behavioral, neurological and substance abuse disorders. For example, estimates made by WHO in 2002 showed that 154 million people globally suffer from depression and 25 million people from schizophrenia. (1) This exerts tremendous social, medical and financial burden. Early intervention and effective management can easily reduce this burden significantly. One other main disorders encountered and constitute real challenge are the psychotic disorders. They constitute 3 to 4 % of all mental disorders (1). They have gained special interest due to its possible chronic course and hence its long term economic and social impact. Cost-effective treatments exist for most disorders and, if correctly applied, could enable most of those affected to become functioning members of society.

References

20 Cites in Article
  1. 1. (2008). World health organization, official site: who. The World Health Organization (WHO, 32-44.
  2. 2. Boronow J (2001). Boronow J (Psychiatr Serv. Psychiatr Serv, 52, 1299-1305.
  3. 3. DSM IV.
  4. 4. D. Casey (1996). Side effect profiles of new antipsychotic agents. J Clin Psychiatry, 11, 40-45.
  5. 5. H. Meltzer,H. Fibiger (1996). Olanzapine: a new typical antipsychotic drug. Neuropsychopharmacology, 14(2), 83-85.
  6. 6. Olanzapine (1997). Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs, 53(2), 281-98.
  7. 7. V. Patrick,E. Levin,S. Schleifer (2005). Antipsychotic Polypharmacy: Is There Evidence for its Use?. J Psychiatr Pract, 11(4), 248-257.
  8. 8. John Newcomer (2005). Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs, 19(Supplement 1), 1???93.
  9. 9. M. Lambert,P. Conus,B. Schimmelmann,P. Eide,J. Ward,H. Yuen,M. Schacht,J. Edwards,D. Naber,P. Mcgorry (2005). Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study. Pharmacopsychiatry, 38(5), 206-13.
  10. 10. J. Kraus,B. Sheitman,A. Cook,R. Reviere,J. Lieberman (2005). Olanzapine Versus Risperidone in Newly Admitted Acutely Ill Psychotic Patients. J Clin Psychiatry, 66(12), 1564-1568.
  11. 11. R. Carnahan,B. Lund,P. Perry,E. Chrischilles (2006). Increased risk of extrapyramidal side‐effect treatment associated with atypical antipsychotic polytherapy. Acta Psychiatr Scand, 113(2), 135-141.
  12. 12. risperidone (2006). A Practical Clinical Trial Comparing Haloperidol, Risperidone, and Olanzapine for the Acute Treatment of First-Episode Nonaffective Psychosis. 2006 Oct, 67(10), 1511-1521.
  13. 13. Comparative antipsychotics,haloperidol schizophrenia (2006). Comparative effectiveness of second-generation antipsychotics and haloperidol in acute schizophrenia. 2006 Nov, 189, 433-440.
  14. 14. Muller Selecting patients for long-acting novel antipsychotic therapy. Australasian Psychiatry
  15. 15. I. Schweitzer (2001). Does risperidone have a place in the treatment of nonschizophrenic patients?. International Clinical Psychopharmacology, 16, 1-19.
  16. 16. S. Stahl Stahl S: Essential pharmacology of antipsychotics and mood stabilizers.
  17. 17. S. Stahl (2002). Stahl S: Psychopharmacologie essentielle – 2002.
  18. 18. S. Stahl (2006). Stahl S: The prescriber’s guide: antipsychotics and mood stabilizers.
  19. 19. Stephen Stahl (2009). Essentials of psychopharmacology.
  20. 20. Amen D: Functional neuroanatomy.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Dr. Amr Guenedi, Dr. Yousif Obeid, Dr. Hanan al Shukri. 2014. "Retrospective Study Evaluating the Management of Psychotic Disorders at Behavioral Medicine Dept a SQUH". Global Journal of Medical Research - A: Neurology & Nervous System GJMR-A Volume 14 (GJMR Volume 14 Issue 9 (A1)).

More Citation Formats

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-A Classification NLMC Code: WM 90
Version of record
v1.2

Issue date
March 3, 2014

Language
English
Order Article Reprint
Experience in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 1K
Total Downloads: 58
All Trends

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Retrospective Study Evaluating the Management of Psychotic Disorders at Behavioral Medicine Dept a SQUH

Amr Guenedi
Amr Guenedi
Yousif Obeid
Yousif Obeid